Fundz

Amlogenyx reported raising $10 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEJul 09, 2026$10M of $20M raised

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Jul 1, 2026)

Round Type

Venture

CaliforniaBiotechnologyHealth CareTherapeutics

Quick answer

Amlogenyx raised $10 Million in a funding round, dated July 1, 2026. Amlogenyx is based in California, United States.

How much did Amlogenyx raise?
Amlogenyx raised $10 Million in a funding round on July 1, 2026.
What does Amlogenyx do?
Amlogenyx Inc. is a subsidiary of Ultragenyx Pharmaceutical, Inc. that focuses on researching and developing novel gene therapies for Alzheimer’s disease and other amyloid diseases.
Where is Amlogenyx based and how big is it?
Amlogenyx is based in California, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Amlogenyx that raised within 45 days of this round, from Fundz verified event records.

  • Apollomics raised $10M on August 14, 2026.
  • bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
  • Khartis Therapeutics raised $50M (Series B) on August 13, 2026.
  • Amplifica Holdings Group raised $26M (Series B) on August 12, 2026.
  • InduPro raised $77M (Series B) on August 12, 2026.
  • Vaderis Therapeutics raised $152M (Series B) on August 11, 2026.

Who to call at Amlogenyx, and when

A new round usually means Amlogenyx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Amlogenyx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amlogenyx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amlogenyx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amlogenyx

Location

California, United States

About

Amlogenyx Inc. is a subsidiary of Ultragenyx Pharmaceutical, Inc. that focuses on researching and developing novel gene therapies for Alzheimer’s disease and other amyloid diseases. They aim to create innovative treatments with the potential to significantly improve patient outcomes. Their first product candidate targets proteins associated with Alzheimer's effects.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amlogenyx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Amlogenyx's next move

See what Strategic adds

Amlogenyx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.